Invention Grant
US09278952B2 Benzoimidazol-2-yl pyrimidine modulators of the histamine H4 receptor
有权
组胺H 4受体的苯并咪唑-2-基嘧啶调节剂
- Patent Title: Benzoimidazol-2-yl pyrimidine modulators of the histamine H4 receptor
- Patent Title (中): 组胺H 4受体的苯并咪唑-2-基嘧啶调节剂
-
Application No.: US14465677Application Date: 2014-08-21
-
Publication No.: US09278952B2Publication Date: 2016-03-08
- Inventor: Matteo Conza , Magali B. Hickey , Stefan Horns , Susanne Lochner
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: JANSSEN PHARMACEUTICA NV
- Current Assignee: JANSSEN PHARMACEUTICA NV
- Current Assignee Address: BE Beerse
- Main IPC: C07D401/14
- IPC: C07D401/14
Abstract:
Benzoimidazol-2-yl pyrimidines, purification methods for the same, and pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus.
Public/Granted literature
- US20140364607A1 BENZOIMIDAZOL-2-YL PYRIMIDINE MODULATORS OF THE HISTAMINE H4 RECEPTOR Public/Granted day:2014-12-11
Information query
